Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Multiple Myeloma 3 Glioma 3 Lymphoma, B-Cell 2 Lymphoma 2 Glioblastoma 2 Fatigue 2 Breast Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Temozolomide 44 Radiotherapy 20 Magnetic Resonance Spectroscopy 13 Irinotecan 13 Carboplatin 11 Bevacizumab 11 Filgrastim 9 Surgical Procedures, Operative 7 Procarbazine 6 sargramostim 5 Vincristine 5 Imatinib Mesylate 5 Etoposide 5 Erlotinib Hydrochloride 5 Carmustine 5 Biopsy 5 etoposide phosphate 4 Peripheral Blood Stem Cell Transplantation 4 Lomustine 4 Immunohistochemistry 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 temsirolimus 3 poly ICLC 3 aldesleukin 3 Thalidomide 3 Surveys and Questionnaires 3 Radiation 3 Polymerase Chain Reaction 3 Gadolinium DTPA 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oligodendroglioma × Neuropsychological Tests × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡